TS-2021

· Beijing Neurosurgical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TS-2021, covering 2024-10-31 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma [Phase 1]